Second Line Endovascular Treatment in Acute DVT

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT06486181

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06486181
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06486181. Randomized; no masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2028-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Second Line Endovascular Treatment in Acute DVT
Condition
Deep Venous Thrombosis
Intervention (Other)
Thrombolysis/Thrombectomy
Lead sponsor
Rush University Medical Center (class: other)

Record details

Record id
cardio:ct-nct06486181
Content hash
f6c697c64b146a177f2a43c790a15face761b31a6114eca1d804c1011f3bbda3